Skip to main content
TipRanks
Go Ultimate75% OFF

Compare TG Therapeutics (NKB2) vs. Competitors

0 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CH:NKB2TG TherapeuticsCHF 7.97B84.45―Moderate BuyUnlock the CH:NKB2 analyst price target with TipRanks PremiumCH:NKB2Unlock the CH:NKB2 top-analyst price target with TipRanks Premium
PTGXProtagonist Therapeutics$124.67$8.14B24.0947.07%Strong BuyUnlock the PTGX analyst price target with TipRanks PremiumCH:NKB2 vs PTGXUnlock the PTGX top-analyst price target with TipRanks Premium
IMVTImmunovant$33.21$6.87B-12.9136.67%Moderate BuyUnlock the IMVT analyst price target with TipRanks PremiumCH:NKB2 vs IMVTUnlock the IMVT top-analyst price target with TipRanks Premium
ARQTArcutis Biotherapeutics$27.33$3.46B116.114.43%Strong BuyUnlock the ARQT analyst price target with TipRanks PremiumCH:NKB2 vs ARQTUnlock the ARQT top-analyst price target with TipRanks Premium
LEGNLegend Biotech$16.11$3.12B-1612.68-45.79%Moderate BuyUnlock the LEGN analyst price target with TipRanks PremiumCH:NKB2 vs LEGNUnlock the LEGN top-analyst price target with TipRanks Premium
KYMRKymera Therapeutics$121.52$10.37B-33.5889.58%Strong BuyUnlock the KYMR analyst price target with TipRanks PremiumCH:NKB2 vs KYMRUnlock the KYMR top-analyst price target with TipRanks Premium

Performance Comparison

-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CH:NKB2TG Therapeutics―――
PTGXProtagonist Therapeutics124.6740.2847.73%
IMVTImmunovant33.219.5240.19%
ARQTArcutis Biotherapeutics27.330.050.18%
LEGNLegend Biotech16.11-13.31-45.24%
KYMRKymera Therapeutics121.5257.2188.96%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts